Vision

NABI is the Korean word for butterfly which represents transformation, a guiding principle for the establishment and operations of the institute. We improve the lives of patients who have suffered from acute brain injury through novel treatment models and new therapeutics.

Mission

To transform the care for brain-injured patients through a multidisciplinary approach that integrates cutting-edge research, clinical expertise, and education.

  • Deliver world-class emergency neurologic care with rapid access to life-saving treatments.
  • Enhance patient access to specialized neurointensivists to improve outcomes and recovery for those facing acute neurologic conditions.
  • Advance the field of neurocritical care and neurologic emergencies through innovative research and collaborative academic efforts.
  • Empower the community by raising awareness and educating brain injury prevention, fostering collaboration, promoting safety measures, and supporting the resilience of affected individuals and their families.
  • Deliver world-class emergency neurologic care with rapid access to life-saving treatments.
  • Train the next generation of neurocritical care professionals, including physicians, advanced practice providers, and nurses, to ensure continued excellence and progress in the field.

Strategic Innovations & Long-term Goals

  • Integrate smart home and assistive technologies to monitor patients in their living environments post-discharge, enhancing safety and early detection of complications.
  • Establish a telehealth-driven cognitive and mobility rehabilitation program utilizing artificial intelligence and machine learning for personalized care recommendations.
  • Partner with technology developers to create wearable devices tailored explicitly for ABI patient needs, focusing on tracking physiological and mobility data.
  • Engage in global collaborations with neurocritical care leaders to position the NABI Institute as a hub for international ABI research and treatment innovation.
  • Develop neurotherapeutic medications for FDA approval.
  • Create an endowment to ensure sustainable funding for research, education, and patient care initiatives.